Reviewing Treatment Options for Advanced Renal Cell Carcinoma: is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
Advances in Therapy（2022）
Key words
Advanced or metastatic renal cell carcinoma (mRCC),Immune checkpoint inhibitor (ICI),Monotherapy,Tyrosine kinase inhibitor (TKI)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined